A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall

被引：4
|
作者：
Broggi, Giuseppe [1 ]
Mazzucchelli, Manuel [1 ]
Covello, Renato [2 ]
Casini, Beatrice [2 ]
Broggi, Giuseppe Maria Vincenzo [3 ,4 ]
Salvatorelli, Lucia [1 ]
Magro, Gaetano [1 ]
机构：
[1] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Anat Pathol, I-95123 Catania, Italy
[2] Regina Elena Natl Canc Inst IRCCS, Pathol Dept, I-00168 Rome, Italy
[3] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Neurol Surg, Policlin Rodolico San Marco Univ Hosp, I-95123 Catania, Italy
[4] Univ Catania, Interdisciplinary Res Ctr Diag & Therapy Brain Tu, I-95123 Catania, Italy
来源：
PATHOLOGY RESEARCH AND PRACTICE | 2022年 / 232卷
关键词：
Mesenchymal chondrosarcoma; STAT6; HEY1-NCOA2 fusion gene; NAB2-STAT6 fusion gene; Diagnostic pitfall; SOLITARY FIBROUS TUMOR; IMMUNOHISTOCHEMISTRY; FUSION;
D O I：
10.1016/j.prp.2022.153803
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
STAT6 is usually considered to be a very sensitive and specific immunomarker for diagnosis of solitary fibrous tumor (SFT), being a surrogate of the NAB2-STAT6 fusion gene identified in most cases of this tumor. STAT6 expression has also been reported in rare cases of other soft tissue tumors, such as low-grade fibromyxoid sar -coma, myxoid/round cell liposarcoma, dedifferentiated liposarcoma and deep fibrous histiocytoma. The aim of this study was to report, for the first time, a case of mesenchymal chondrosarcoma showing diffuse aberrant immunohistochemical expression of STAT6. Molecular biology, showing the HEY1-NCOA2 fusion gene, was crucial to rule out SFT.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] MENINGEAL BASED TUMORS: ROLE OF STAT6 EXPRESSION
    Sahay, Ayushi
    Kadam, Vinayak
    Moiyadi, Aliasgar
    Gupta, Tejpal
    Goda, JayantSastri
    Shetty, Prakash
    Jalali, Rakesh
    Epari, Sridhar
    NEURO-ONCOLOGY, 2017, 19 : 133 - 133
  • [32] Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review
    Aleksandra Petrovic
    Aurélie Obéric
    Alexandre Moulin
    Mehrad Hamedani
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1609 - 1617
  • [33] The Expression of STAT6 in Mesenchymal Tumors: An Immunohistochemical Study with an Emphasis on the Morphological Spectrum of Solitary Fibrous Tumor
    Matsuyama, A.
    Kasai, T.
    Shibuya, R.
    Shiba, E.
    Nakamoto, M.
    Hisaoka, M.
    LABORATORY INVESTIGATION, 2014, 94 : 22A - 23A
  • [34] Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review
    Petrovic, Aleksandra
    Oberic, Aurelie
    Moulin, Alexandre
    Hamedani, Mehrad
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (09) : 1609 - 1617
  • [35] The Expression of STAT6 in Mesenchymal Tumors: An Immunohistochemical Study with an Emphasis on the Morphological Spectrum of Solitary Fibrous Tumor
    Matsuyama, A.
    Kasai, T.
    Shibuya, R.
    Shiba, E.
    Nakamoto, M.
    Hisaoka, M.
    MODERN PATHOLOGY, 2014, 27 : 22A - 23A
  • [36] Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errors
    Huang, Michelle
    Sakhdari, Ali
    EJHAEM, 2022, 3 (04): : 1433 - 1434
  • [37] Stat6 nuclear export elements are unique from other stat family members
    Ericksen, MB
    Dames, MO
    Hershey, GKK
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S143 - S143
  • [38] Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis
    Fukushi, S.
    Yamasaki, K.
    Aiba, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) : 990 - 996
  • [39] STAT6—a potential new drug target for treatment of PKD
    Nature Reviews Nephrology, 2012, 8 (1) : 2 - 2
  • [40] New STAT6 inhibitors with potential therapeutic application in asthma
    Zamorano, Jose
    Cortes, Jose R.
    Perez-G, Moises
    Fernandez, Carlos
    Gonzalez-Nunez, Maria A.
    JOURNAL OF IMMUNOLOGY, 2007, 178
12345